Detalles de la búsqueda
1.
A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients.
J Immunol
; 206(3): 580-587, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33298615
2.
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT.
Blood
; 125(12): 1986-94, 2015 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25617426
3.
Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.
Vaccines (Basel)
; 12(4)2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38675779
4.
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer.
Front Immunol
; 14: 1271449, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37920460
5.
Adjuvant Treatment for Breast Cancer Patients Using Individualized Neoantigen Peptide Vaccination-A Retrospective Observation.
Vaccines (Basel)
; 10(11)2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36366390
6.
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.
J Immunother Cancer
; 9(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33431630
7.
Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers.
J Cancer Res Clin Oncol
; 132(4): 265-74, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16374613
8.
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts.
Oncotarget
; 7(47): 76902-76919, 2016 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27708227
9.
Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Clin Cancer Res
; 9(12): 4376-86, 2003 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14555509
10.
Identification of a Novel Immunodominant HLA-B*07: 02-restricted Adenoviral Peptide Epitope and Its Potential in Adoptive Transfer Immunotherapy.
J Immunother
; 38(7): 267-75, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26261890
11.
Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy.
Oncoimmunology
; 4(5): e1002723, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26155389
12.
Tumor-associated antigen profiling in breast and ovarian cancer: mRNA, protein or T cell recognition?
J Cancer Res Clin Oncol
; 129(7): 397-409, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12836015
13.
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation.
J Clin Oncol
; 31(1): 39-48, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23169501
14.
Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers.
J Immunother
; 35(9): 661-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23090075
Resultados
1 -
14
de 14
1
Próxima >
>>